Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial.
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Introduction: The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. Methods: All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. Results: A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Conclusions: Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Annotation: Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). Trial registration: ISRCTN10288268
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 1×
“In addition, Sequential Organ Failure Assessment (SOFA) scores were calculated daily [16] to stratify and monitor disease severity.”
MethodKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 3×
“Accordingly, Kumar and colleagues [1] could show that the hospital mortality rate for patients with septic shock increased by about 7% per hour within the first six hours of delayed antibiotic administration.”
BackgroundChastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 3×
“Singh and colleagues [12] investigated intensive care patients with pneumonia and found that discontinuing antibiotic treatment after three days in the absence of a suspected infection did not worsen outcome.”
BackgroundIregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956 · cited 1×
“A study from the USA was able to demonstrate that patients with ventilator-associated pneumonia who received antibiotic therapy only 24 hours after established diagnosis, exhibited a seven times higher mortality rate compared with patients started on adequate therapy earlier [21].”
ResultHARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Engel, C., Brunkhorst, F. M., Bone, H.-G., Brunkhorst, R., Gerlach, H., Grond, S., Gruendling, M., Huhle, G., Jaschinski, U., John, S., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0517-7 · Cited by 615 · cited 1×
“Sepsis continues to be the leading cause of morbidity and in its severe form (severe sepsis, septic shock, and multi-organ dysfunction) of mortality in intensive care patients [19].”
BackgroundUse of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605 · cited 5×
“More recent studies suggest that a PCT-based algorithm significantly shortens the length of antibiotic therapy without affecting the treatment success and outcome [8,9].”
BackgroundResultInfluentialEpidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Procalcitonin in bacterial infections - hype, hope, more or less?
Christ-Carin, M. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11169 · Cited by 367
Meisner, M., Tschaikowsky, K., Palmaers, T., & Schmidt, J. (1999) · Critical Care · doi:10.1186/cc306 · Cited by 326 · cited 1×
“Standard laboratory variables such as CRP have a slow kinetic profile rendering it an inappropriate marker for a fast evaluation of the dynamics of an infection [18].”
BackgroundBody temperature alterations in the critically ill
Peres Bota, D., Lopes Ferreira, F., M�lot, C., & Vincent, J. L. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2166-z · Cited by 295 · cited 1×
“On the other hand, fever and leukocytosis may not necessarily be present in clinically manifest sepsis [3,4].”
BackgroundOutcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Oberhoffer, M., Vogelsang, H., Rußwurm, S., Härtung, T., & Reinhart, K. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.060 · Cited by 148 · cited 3×
“The same applies for the leukocyte count [3].”
BackgroundResultBossink, A. W. J., Groeneveld, A. B. J., & Thijs, L. G. (1999) · Clinical Infectious Diseases · doi:10.1086/520222 · Cited by 96
Yu, V. L., & Singh, N. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2201-0 · Cited by 64 · cited 2×
“Drug-induced side effects, such as allergic reactions, antibiotic-associated colitis, and the risk of life-threatening infections from multi-resistant bacteria, significantly rise [11-13].”
BackgroundThe Clinical Host Response to Microbial Infection in Medical Patients With Fever
Bossink, A. W. J., Groeneveld, A. B. J., Hack, C. E., & THIJS, L. G. (1999) · CHEST Journal · doi:10.1378/chest.116.2.380 · Cited by 41 · cited 1×
“0°C), Bossink and colleagues [5] were able to demonstrate that at least two SIRS criteria were present in 95% of these patients and clinical suspicion of sepsis in 71%, but only 44% had microbiologic proven infection.”
Background(1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.37.6.697 · Cited by 30
Optimizing Antibiotic Treatment for Ventilator‐Associated Pneumonia
Micek, S. T., Heuring, T., Hollands, J. M., Shah, R. A., & Kollef, M. H. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.2.204 · Cited by 29 · cited 1×
“Micek and colleagues [20] also studied the length of antibiotic therapy in respiratory associated pneumonia and postulated a therapeutic interval of seven to eight days as sufTable 2”
BackgroundAntibiotikatherapie der Sepsis
Welte, T. (2004) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2004-836084 · Cited by 17
Jonas, D., Schwab, F., Gastmeier, P., R�den, H., Daschner, F. D., & Meyer, E. (2004) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-004-0804-9 · Cited by 13
Welte, T. (2006) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-006-0721-2 · Cited by 10 · cited 1×
“One of the main reasons for the increasing rate of resistance is noncontrolled antibiotic use and long-term treatment in intensive care wards [14,23].”
BackgroundEinfluss des Antibiotikaverbrauchs auf Resistenzbildung und -selektion
Harbarth, S. (2007) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-2007-971165 · Cited by 10 · cited 3×
“On the other hand, if antibiotic treatment is inadequate and too long the development of antibiotic resistance is favoured [11,14].”
BackgroundEngelmann, L. (2006) · Steinkopff eBooks · doi:10.1007/978-3-7985-1729-5_1 · Cited by 4
Diagnostik und Intensivtherapie bei Sepsis und Multiorganversagen
Engelmann, L., & Schuster, H.-P. (2006) · Steinkopff eBooks · doi:10.1007/978-3-7985-1729-5 · Cited by 4
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
“PAF has also been effective in the ICU [24, 25].”
InfluentialSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Metadata
- Authors
- Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S.
- Affiliations
- Westküstenkliniken Brunsbüttel und Heide gGmbH (DE)
- University Hospital Schleswig-Holstein (DE)
- Venue
- Critical Care
- Published
- 2009-06-03
- Volume
- 13
- Issue
- 3
- Pages
- R83-R83
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2717450
- OpenAlex
- W2109928541
- Semantic Scholar
- 269d1d25f4ebc2ac9fd79ee6e50e38b8ebd7138d
- Cited by
- 315
- References
- 29
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 22 · 2020: 9 · 2019: 16 · 2018: 21 · 2017: 32 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 28 · 2012: 32
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- procalcitonin, antibiotic duration, antibiotic stewardship, surgical intensive care patients, bacterial infection, systemic inflammatory response syndrome, antibiotic de-escalation, antimicrobial resistance, inflammatory markers
- MeSH terms
- Aged, Anti-Bacterial Agents, Calcitonin, Diagnosis, Differential, Female, Humans, Male, Postoperative Complications, Prospective Studies, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide, Drug Monitoring, Systemic Inflammatory Response Syndrome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.